Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease

BACKGROUND: The benefits of aspirin as an anti-platelet agent are well established; however, there has been much debate about the lack of uniformity in the efficacy of aspirin to inhibit platelet function. In some patients, aspirin fails to inhibit platelets even where compliance has been verified,...

Descripción completa

Detalles Bibliográficos
Autores principales: Raichand, Smriti, Moore, David, Riley, Richard D, Lordkipanidzé, Marie, Dretzke, Janine, O’Donnell, Jennifer, Jowett, Sue, Bayliss, Sue, Fitzmaurice, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600664/
https://www.ncbi.nlm.nih.gov/pubmed/23442317
http://dx.doi.org/10.1186/2046-4053-2-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600664/
https://www.ncbi.nlm.nih.gov/pubmed/23442317
http://dx.doi.org/10.1186/2046-4053-2-16

Ejemplares similares